What is nootropics tablets?

The one nootropic tablet that has always worked: the caffeine tablet as the benchmark, what it does, what it costs, and why every other tablet is read against it

What nootropic tablets are is a question with a shelf word in it and a format word in it, and neither word tells a buyer anything about what is inside, so the honest page starts from the one tablet on the shelf that has always done what the shelf promises and reads everything else against it. That tablet is the caffeine tablet: 100mg or 200mg of caffeine pressed with a little filler, sold in UK pharmacies and supermarkets for decades under brand names every student knows, long before the word nootropic reached the high street, at a penny or two a tablet. It is the reference stimulant of cognitive and sports research, and the trials are unambiguous that a 100 to 200mg caffeine tablet produces the same improvements in reaction time, vigilance, sustained attention and physical performance as the equivalent dose in coffee, within thirty to sixty minutes, fading over a five to six hour half-life, with the same bills attached, sleep lost after a mid-afternoon dose, anxiety and arousal rising with the milligrams, tolerance with daily use and a withdrawal headache on stopping. Its virtues as a benchmark are exactly the things the rest of the shelf lacks: a known compound, a known dose printed on the box, a known time course, a price near zero and a trial literature measured in decades. So the test for any other nootropic tablet is a single question with two parts: what does this tablet contain that the caffeine tablet does not, and does that extra ingredient have a trial behind it at the dose in the tablet? A tablet that contains caffeine plus something unproven is a caffeine tablet with a markup; a tablet that contains no caffeine is asking to be judged on its other contents alone, which is fair and usually fatal; and a tablet whose caffeine content is hidden in a proprietary blend has removed the one number that would let the buyer place it against the benchmark, which is the most informative thing a label can do. This is not a recommendation to take caffeine tablets, which have their own ceiling and their own bedtime arithmetic and are a worse habit than coffee for most people because the dose is so easy to repeat; it is a recommendation to use the caffeine tablet as the ruler, because a ruler that has always measured true is the only honest way to read a shelf built on a word.

The rest of the tablet shelf read against the ruler: B vitamins, single botanicals, proprietary blends and mushroom tablets, with the format's own facts, and where lion's mane fits

Read against the ruler, the rest of the tablet shelf sorts itself into four groups. The B-vitamin tablets, sold as brain, energy or focus tablets, are the one group with lawful sentences: pantothenic acid holds contribution to normal mental performance, B6, B12 and folate hold normal psychological function and the reduction of tiredness and fatigue, and a tablet meeting the register's threshold may print those words, which it does something measurable to deserve only in a person who was short of the vitamin, so a B-vitamin tablet is a lawful product that a blood test or a restricted diet justifies and a replete person notices nothing from. The single-botanical tablets, ginkgo, bacopa, Rhodiola and their relatives, contain one named plant extract at a stated dose, which is honest labelling, and carry small and mixed trial literatures, often industry-funded, that the meta-analytic reviews of supplements and cognition in healthy adults pool to small or null effects, with no authorised claim for any of them; against the ruler they contain something the caffeine tablet does not and the something has a thin file. The multi-ingredient brain tablets are the group the word nootropic was adopted to sell, a dozen ingredients in a proprietary blend with one total and no per-ingredient dose, and they fail the ruler test by design: their caffeine, from guarana or green tea, is usually in the blend and uncounted, so the one ingredient that works cannot be placed against the benchmark, and their other ingredients cannot be placed against their trials because the doses are hidden. The mushroom tablets are rare, and the reason is manufacturing: lion's mane and the other culinary fungi are sold almost entirely as capsules, because a loose extract powder fills a shell without the binders, disintegrants and lubricants that compression into a tablet requires, and the lion's mane tablets that do exist tend to be plain milled fruiting body or mycelium powder, which compresses more easily than a sticky extract, labelled in milligrams with no ratio. A lion's mane tablet is therefore judged exactly as a capsule is, on the mushroom's sixteen-week trial in thirty older adults and its young-adult pilot, on its tissue, ratio and glucan figure, and additionally on its excipient line, and against the ruler it contains something the caffeine tablet does not, a culinary fungus with two small studies and no claim, which is an honest extra honestly sized. The format's own facts apply to every group: a tablet holds more material per unit than a capsule and has no shell, so no gelatine question, against binders, disintegrants, lubricants and sometimes a coating, a disintegration step the formulation controls and a harder swallow. A nootropic tablet, then, is any tablet sold under the word; the caffeine tablet is the only one that reliably does what the word promises; and a buyer reads the others by asking what they add and whether the addition has a trial. The mushroom in the format its extract actually fits, with the extract stated: a stated 5:1 fruiting body extract labelled 1500mg mushroom equivalent, 120 capsules for £15.49, 120 days at 13p, vegan HPMC shell, UK made under GMP and BRC, independently lab tested, caffeine free, which is to say a tablet-shelf extra sold honestly as a capsule, with nothing in it the ruler would measure.

What to check on the label